AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

πŸ‡ΏπŸ‡Ό

SITAGLIPTIN PHOSPHATE in Zimbabwe

9 products registered with MCAZ β€” 9 active

Brand / ProductReg. No.HolderStatusExpires
SITALIP
TABLET, COATED; ORAL
2026/17.7/7452INNOVATA PHARMACEUTICALSactive3 Jun 2031
SITALIP
TABLET, COATED; ORAL
2026/17.7/7453INNOVATA PHARMACEUTICALSactive3 Jun 2031
SITALIP
TABLET, COATED; ORAL
2026/17.7/7454INNOVATA PHARMACEUTICALSactive3 Jun 2031
SITALIN-100
TABLET, COATED; ORAL
2026/17.7/7305LINCOLN PHARMACEUTICALS LIMITEDactive8 Feb 2031
SITALIN-50
TABLET, COATED; ORAL
2026/17.7/7303LINCOLN PHARMACEUTICALSactive8 Feb 2031
SITAPRIDE - 50
TABLET, COATED; ORAL
2025/17.7/7085MICRO LABS LIMITEDactive25 Sept 2030
SITAPRIDE- 100
TABLET, COATED; ORAL
2025/17.7/7086MICRO LABS LIMITEDactive25 Sept 2030
SITAPRIDE- 25
TABLET, COATED; ORAL
2025/17.7/7084MICRO LABS LIMITEDactive25 Sept 2030
GLINSIP 25
TABLET, COATED; ORAL
2023/17.7/6435HETERO LABS LTDactive30 Jun 2028

SITAGLIPTIN PHOSPHATE β€” MCAZ Registration Details

MCAZ (Zimbabwe) has 9 registered products containing SITAGLIPTIN PHOSPHATE, of which 9 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.

Track SITAGLIPTIN PHOSPHATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

Sitagliptin Phosphate β€” Zimbabwe (MCAZ) | AfricaRegulatory